Induction of programmed cell death in human retinoblastoma Y79 cells by C2-ceramide

Molecular and Cellular Biochemistry

Volumn 185, Issue 1-2, 1998, Pages 7-15

  Vento, Renza ^a   Giuliano, Michela ^a   Lauricella, Marianna ^a   Carabillò, Maria ^a   Di Liberto, Diana ^a   Tesoriere, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Apoptosis; Ceramide; Human retinoblastoma cells

Indexed keywords

ACRIDINE ORANGE; CERAMIDE; CYCLOHEXIMIDE; DACTINOMYCIN; ETHIDIUM BROMIDE; FLUORESCENT DYE; INTERLEUKIN 1BETA; LIPOCORTIN 5; MESSENGER RNA; OKADAIC ACID; PHOSPHATIDYLSERINE; PROTEIN BCL 2; PROTEIN P53; SPHINGOMYELIN PHOSPHODIESTERASE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL DEATH; CELL DEGENERATION; CELL SIZE; CELL STRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RETINOBLASTOMA;

APOPTOSIS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL SURVIVAL; CERAMIDES; DNA FRAGMENTATION; HUMANS; INTERLEUKIN-1; NUCLEOSOMES; OKADAIC ACID; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031655452     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006836428202     Document Type: Article

References (39)

1. Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995
2. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh D: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267: 1506-1510, 1995
3. Kamada S, Shinto AA, Tsujimura Y, Takahashi T, Noda T, Kitamura Y, Kondoh H, Tsujimoto Y: Bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in the thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res 55: 354-359, 1995
4. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14: 18). Nature 349: 254-256, 1991
5. Martin SJ, Green DR, Cotter TG: Dicing with death: Dissecting the components of the apoptosis machinery. TIBS 19: 26-30, 1994
6. Gerschenson LE, Rotello RJ: Apoptosis, a different type of cell death. FASEB J 6: 2450-2455, 1992
7. Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff MC: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70: 31-46, 1992
8. Oberhammer F, Fritsch G, Schmied M, Pavelka M, Printz D, Purchio T, Lassman H, Schulte-Hermann R: Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J Cell Sci 104: 317-326, 1993
9. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA,Wakeling AK, Walker PR, Sikorrska M: Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 3679-3684, 1993
10. Masters JN, Finch CE, Sapolsky RM: Glucocorticoid endangerment of hippocampal neurons does not involve deoxyribonucleic acid cleavage. Endocrinology 124: 3083-3088, 1989
11. Mesner PW, Winters TR, Green SH: Nerve growth factor withdrawal-induced cell death in neuronal PC 12 cells resembles that in sympathetic neurons. J Cell Biol 119: 1669-1680, 1992
12. Nakamura M, Yagi H, Kayaba S, Ishii T, Ohtsu S, Gotoh T, Itoh T: Most thymocytes die in the absence of DNA fragmentation. Arch Histol Cytol 58: 249-256, 1995
13. Nakamura M, Yagi H, Kayaba S, Ishii T, Gotoh T, Ohtsu S, Itoh T: Death of germinal center B cells without DNA fragmentation. Eur J Immunol 26: 1211-1216, 1996
14. Pushkareva M, Obeid LM, Hannun YA: Ceramide: An endogenous regulator of apoptosis and growth suppression. Immun Today 16: 294-297, 1995
15. Jarvis WD, Grant S, Kolesnick RN: Ceramide and the induction of apoptosis. Clin Cancer Res 2: 1-6, 1996
16. Okazaki T, Bell RM, Hannun YA: Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 264: 19076-19080, 1989
17. Kim MY, Linardic C, Obeid L, Hannun Y: Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. J Biol Chem 266: 484-489, 1991
18. Ballou LR, Chao CP, Holness MA, Barker SC, Raghow R: Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267: 20044-20050, 1992
19. Hannun YA, Obeid LM: Ceramide: An intracellular signal for apoptosis. TIBS 20: 73-77, 1995
20. Dbaibo GS, Pushkareva MY, Jayadev S, Schwarz JK, Horowitz JM, Obeid LM, Hannun YA: Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci USA 92: 1347-51, 1995
21. Bing A, Dou QP: Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 beta converting enzyme-like protease as candidate. Cancer Res 56: 438-442, 1996
22. Kuroki J, Hirokawa M, Kitabayashi A, Lee M, Horiuchi T, Kawabata Y, Miura AB: Cell permeable ceramide inhibits the growth of B lymphoma Raji cells lacking TNF-alpha-receptors by inducing G0/G1 arrest but not apoptosis: a new model for dissecting cell-cycle arrest and apoptosis. Leukemia 10: 1950-1958, 1996
23. McConkey DJ, Goodrich D, Bucana C, Klostergaard J: The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cella. Oncogene 13: 1693-1700, 1996
24. Vento R, Tesoriere G, Giuliano M, Calvaruso G, Lauricella M, Carabillo M: Synthesis of insulin and its effects in Y79 human retinoblastoma cells. Exp Eye Res 59: 221-229, 1994
25. Ginliano M, Vento R, Lauricella M, Calvaruso G, Carabillo M, Tesoriere G: Role of insulin like growth factors in autocrine growth of human retinoblastoma Y79 cells. Eur J Biochem 236: 523-532, 1996
26. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallic BL, Murphree AL, Strong LC, White RL: Genetic origin of mutation predisposing to retinoblastoma. Nature 305: 779-784, 1983
27. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983
28. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420, 1994
29. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schle RCAA, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545-1556, 1995
30. Mishell BB, Shiigi SM, Henry C, Chan EL, North, J, Gallily R, Slomich M, Miller K, Marbrook J, Parks D, Good AH: Preparation of mouse cell suspension. In: BB Mishell and Sm Shiigi(eds). Selected Methods in Cellular Immunology, WH Freeman, New York pp21-22
31. Martin SJ, Lennon SV, Bonham AM, Cotter TG: Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145: 1859-1867, 1990
32. Bissonette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by Bcl-2. Nature 359: 552-554, 1992
33. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR: Phosphatidylserine externalization during CD95 and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 271: 28753-28756, 1996
34. Mathias S, Younes A, Kan CC, Orlow I, Joseph C, Kolesnick N: Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259: 519-522, 1993
35. Wolff RA, Dobrowsky RT, Bielawska A, Obeid LM, Hannun YA: Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem 269: 19605-19609, 1994
36. Falcieri E, Martelli AM, Bareggi R, Cataldi A, Cocco L: The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in MOLT-4 cells without concomitant DNA fragmentation. Biochem. Biophys Res Comm 193: 19-25, 1993
37. Jacobson MD, Burne JF, Raff MC: Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J: 13: 1899-1910, 1994
38. Schulze-OsthoffK, Walczak H, Krammer PH: Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127: 15-20, 1994
39. Haldar S, Croce CM: Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511, 1993